Back to top

Image: Bigstock

Strength seen in Haemonetics (HAE): Stock Soars 10.5%

Read MoreHide Full Article

Haemonetics Corporation (HAE - Free Report) was a big mover last session, as the company saw its shares rise over 11% on the day. The upside was driven after the company announced first-quarter fiscal 2017 results. The news also led to far more shares changing hands than in a normal session, resulting in solid volume. This breaks the recent trend for the company as the stock is now trading above the volatile price range of $29.22 to $30.55 in the past one-month time frame.

None of the estimates for this stock were revised over the past 30 days while the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Haemonetics Corporation has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Another better-ranked stock in the Medical Services industry is NuVasive, Inc. NUVA, sporting a Zacks Rank #1 (Strong Buy).

Is HAE going up? Or down? Predict to see what others think: Up or Down

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Haemonetics Corporation (HAE) - free report >>

Published in